Abstract:Endoplasmic reticulum (ER) stress is an important mechanism in the progression of chronic and acute liver diseases, especially in the progression and recovery of liver fibrosis. Excessive and long-term ER stress induces apoptosis. ER stress-induced apoptosis is considered to be an important pathway in the development of liver fibrosis. Cyclooxygenase-2 (COX-2) induction is also closely related to ER stress. In our previous studies, we showed that celecoxib, a COX-2 inhibitor, improves liver fibrosis and portal hypertension. However, the role and mechanism of celecoxib in alleviating liver fibrosis remain unclear.To investigate whether celecoxib alleviates liver fibrosis by inhibiting hepatocyte apoptosis the ER stress response.Cirrhosis was induced by intraperitoneal injections of thioacetamide (TAA) for 16 wk (injection dose is 200 mg/kg per 3 d for the first 8 wk and 100 mg /kg per 3 d after 8 wk). Thirty-six male Sprague-Dawley rats were randomly divided into three groups, namely, control group, TAA group, and TAA + celecoxib group. In the last 8 wk, TAA-induced cirrhotic rats received celecoxib (20 mg/kg/day) or the vehicle by gastric gavage. After 16 wk, the rats were sacrificed, and serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and albumin (ALB) were detected. The hepatic fibrosis areas were evaluated by Sirius red staining and the degree of fibrosis was assessed by measuring the level of hydroxyproline. ER stress levels were evaluated by detecting the marker proteins glucose-regulated protein 78 (GRP78), CCAAT/enhancer binding protein homologous protein (CHOP), PKR-like ER protein kinase (PERK), activating transcription factor 6 (ATF6), and inositol-requiring enzyme 1 alpha (IRE1α). Apoptosis levels were evaluated by detecting caspase-12 and caspase-3.The serum ALT and AST levels in the liver were significantly reduced by celecoxib; however, the serum ALB had no significant changes. Celecoxib significantly reduced the degree of liver fibrosis and the levels of hydroxyproline (-38% and -25.7%, respectively, < 0.01). Celecoxib ameliorated ER stress by reducing the level of GRP78 compared to the TAA group ( < 0.05). Consistently, after celecoxib administration, the upregulation of TAA-induced hepatic apoptosis markers (caspase-12 and caspase-3) and CHOP were significantly inhibited. In addition, after celecoxib treatment, the expression of key molecules associated with ER stress (PERK, ATF6, and IRE1) was decreased ( < 0.05).Therapeutic administration of celecoxib effectively reduces hepatic apoptosis in TAA-induced cirrhotic rats. The mechanism of action may be attributed to the suppression of CHOP expression, which subsequently inhibits ER stress.

Sa1684 Attenuation of Hepatic Fibrogenesis and Portal Hypertension in the Cirrhotic Rats with Celecoxib and Octreotide

The Effect of Lecithins Coupled Decorin Nanoliposomes on Treatment of Carbon Tetrachloride-Induced Liver Fibrosis

Enhanced anti-fibrogenic effects of novel oridonin derivative CYD0692 in hepatic stellate cells

Celecoxib Attenuates Hepatic Cirrhosis Through Inhibition of Epithelial-To-Mesenchymal Transition of Hepatocytes

Enhanced Effects of Novel Oridonin Analog Cyd0682 for Hepatic Fibrosis

Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats Through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis.

Suppressive Effects of Novel Oridonin Derivative CYD0625 on Activated Hepatic Stellate Cells

Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury.

Mo1000 Octreotide and Celecoxib Synergistically Ameliorate Portal Hypertension of the Cirrhotic Rats Through Dual Inhibitory Effects on the Angiogenesis and Sinusoidal Remodeling

Sa1004 Celecoxib Ameliorated Fibrosis and Portal Pressure Through Antiangiogenesis in Cirrhotic Rats

Novel Oridonin Analog CYD0682 Inhibits Hepatic Stellate Cell Activation via the Heat Shock Protein 90-Dependent STAT3 Pathway

Protein extracts of Crassostrea gigas alleviate CCl₄-induced hepatic fibrosis in rats by reducing the expression of CTGF, TGF-β1 and NF-κB in liver tissues.

Celecoxib Ameliorates Liver Cirrhosis Via Reducing Inflammation and Oxidative Stress along Spleen-Liver Axis in Rats.

Eggshell Membrane Ameliorates Hepatic Fibrogenesis in Human C3A Cells and Rats Through Changes in PPARγ-Endothelin 1 Signaling.

Disruption of Cholangiocyte-B Cell Crosstalk by Blocking the CXCL12-CXCR4 Axis Alleviates Liver Fibrosis.

Celecoxib attenuates hepatocyte apoptosis by inhibiting endoplasmic reticulum stress in thioacetamide-induced cirrhotic rats

Synthesis and Anti-Hepaticfibrosis of Glycyrrhetinic Acid Derivatives with Inhibiting COX-2

Celecoxib Derivative OSU-03012 Inhibits the Proliferation and Activation of Hepatic Stellate Cells by Inducing Cell Senescence.

Anti-Fibrosis Effects Of Huisheng Oral Solution In Ccl4-Induced Hepatic Fibrosis In Rat

The Transcriptomic Profile Shows the Protective Effects of Celecoxib on Cirrhotic Splenomegaly.

Celecoxib Reduces Hepatic Vascular Resistance in Portal Hypertension by Amelioration of Endothelial Oxidative Stress.